307 related articles for article (PubMed ID: 33963961)
1. Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival.
Crotty EE; Smith SMC; Brasel K; Pakiam F; Girard EJ; Connor YD; Zindy F; Mhyre AJ; Roussel MF; Olson JM
J Neurooncol; 2021 Jun; 153(2):225-237. PubMed ID: 33963961
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophages in SHH subgroup of medulloblastomas.
Margol AS; Robison NJ; Gnanachandran J; Hung LT; Kennedy RJ; Vali M; Dhall G; Finlay JL; Erdreich-Epstein A; Krieger MD; Drissi R; Fouladi M; Gilles FH; Judkins AR; Sposto R; Asgharzadeh S
Clin Cancer Res; 2015 Mar; 21(6):1457-65. PubMed ID: 25344580
[TBL] [Abstract][Full Text] [Related]
3. Paracrine regulation of colony-stimulating factor-1 in medulloblastoma: implications for pathogenesis and therapeutic interventions.
Papavasiliou AK; Mehler MF; Mabie PC; Marmur R; Qingbin S; Keating RF; Kessler JA
Neurosurgery; 1997 Oct; 41(4):916-23. PubMed ID: 9316054
[TBL] [Abstract][Full Text] [Related]
4. CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model.
Tan IL; Arifa RDN; Rallapalli H; Kana V; Lao Z; Sanghrajka RM; Sumru Bayin N; Tanne A; Wojcinski A; Korshunov A; Bhardwaj N; Merad M; Turnbull DH; Lafaille JJ; Joyner AL
Oncogene; 2021 Jan; 40(2):396-407. PubMed ID: 33159168
[TBL] [Abstract][Full Text] [Related]
5. ATOH1 Promotes Leptomeningeal Dissemination and Metastasis of Sonic Hedgehog Subgroup Medulloblastomas.
Grausam KB; Dooyema SDR; Bihannic L; Premathilake H; Morrissy AS; Forget A; Schaefer AM; Gundelach JH; Macura S; Maher DM; Wang X; Heglin AH; Ge X; Zeng E; Puget S; Chandrasekar I; Surendran K; Bram RJ; Schüller U; Talyor MD; Ayrault O; Zhao H
Cancer Res; 2017 Jul; 77(14):3766-3777. PubMed ID: 28490517
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary administration of a CSF-1R inhibitor alters the balance of tumor-associated macrophages and supports first-line chemotherapy in a lung cancer model.
Zhang H; Almuqbil RM; Alhudaithi SS; Sunbul FS; da Rocha SRP
Int J Pharm; 2021 Apr; 598():120350. PubMed ID: 33545279
[TBL] [Abstract][Full Text] [Related]
7. Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.
Stafford JH; Hirai T; Deng L; Chernikova SB; Urata K; West BL; Brown JM
Neuro Oncol; 2016 Jun; 18(6):797-806. PubMed ID: 26538619
[TBL] [Abstract][Full Text] [Related]
8. Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Ao JY; Zhu XD; Chai ZT; Cai H; Zhang YY; Zhang KZ; Kong LQ; Zhang N; Ye BG; Ma DN; Sun HC
Mol Cancer Ther; 2017 Aug; 16(8):1544-1554. PubMed ID: 28572167
[TBL] [Abstract][Full Text] [Related]
9. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.
Van Overmeire E; Stijlemans B; Heymann F; Keirsse J; Morias Y; Elkrim Y; Brys L; Abels C; Lahmar Q; Ergen C; Vereecke L; Tacke F; De Baetselier P; Van Ginderachter JA; Laoui D
Cancer Res; 2016 Jan; 76(1):35-42. PubMed ID: 26573801
[TBL] [Abstract][Full Text] [Related]
10. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
11. Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality.
Dang MT; Gonzalez MV; Gaonkar KS; Rathi KS; Young P; Arif S; Zhai L; Alam Z; Devalaraja S; To TKJ; Folkert IW; Raman P; Rokita JL; Martinez D; Taroni JN; Shapiro JA; Greene CS; Savonen C; Mafra F; Hakonarson H; Curran T; Haldar M
Cell Rep; 2021 Mar; 34(13):108917. PubMed ID: 33789113
[TBL] [Abstract][Full Text] [Related]
12. Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages.
Bonelli S; Geeraerts X; Bolli E; Keirsse J; Kiss M; Pombo Antunes AR; Van Damme H; De Vlaminck K; Movahedi K; Laoui D; Raes G; Van Ginderachter JA
FEBS J; 2018 Feb; 285(4):777-787. PubMed ID: 28834216
[TBL] [Abstract][Full Text] [Related]
13. Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma.
Zhu L; Yang Y; Li H; Xu L; You H; Liu Y; Liu Z; Liu X; Zheng D; Bie J; Li J; Song C; Yang B; Luo J; Chang Q
Cancer Lett; 2022 Jun; 535():215630. PubMed ID: 35304257
[TBL] [Abstract][Full Text] [Related]
14. CSF-1R inhibition alters macrophage polarization and blocks glioma progression.
Pyonteck SM; Akkari L; Schuhmacher AJ; Bowman RL; Sevenich L; Quail DF; Olson OC; Quick ML; Huse JT; Teijeiro V; Setty M; Leslie CS; Oei Y; Pedraza A; Zhang J; Brennan CW; Sutton JC; Holland EC; Daniel D; Joyce JA
Nat Med; 2013 Oct; 19(10):1264-72. PubMed ID: 24056773
[TBL] [Abstract][Full Text] [Related]
15. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
[TBL] [Abstract][Full Text] [Related]
16. Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma.
Maximov V; Chen Z; Wei Y; Robinson MH; Herting CJ; Shanmugam NS; Rudneva VA; Goldsmith KC; MacDonald TJ; Northcott PA; Hambardzumyan D; Kenney AM
Nat Commun; 2019 Jun; 10(1):2410. PubMed ID: 31160587
[TBL] [Abstract][Full Text] [Related]
17. Diverse in vivo effects of soluble and membrane-bound M-CSF on tumor-associated macrophages in lymphoma xenograft model.
Liao J; Feng W; Wang R; Ma S; Wang L; Yang X; Yang F; Lin Y; Ren Q; Zheng G
Oncotarget; 2016 Jan; 7(2):1354-66. PubMed ID: 26595525
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.
Peng X; Hou P; Chen Y; Dai Y; Ji Y; Shen Y; Su Y; Liu B; Wang Y; Sun D; Jiang Y; Zha C; Xie Z; Ding J; Geng M; Ai J
J Exp Clin Cancer Res; 2019 Aug; 38(1):372. PubMed ID: 31438996
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma.
Zhang J; Yuan X; Wang Y; Liu J; Li Z; Li S; Liu Y; Gong X; Sun Y; Wu W; Sun L; Du S; Wang T
Front Oncol; 2022; 12():893132. PubMed ID: 35860588
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2.
Digiacomo G; Ziche M; Dello Sbarba P; Donnini S; Rovida E
FASEB J; 2015 Jun; 29(6):2545-54. PubMed ID: 25757564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]